Avet Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AVET, and what generic and branded alternatives to AVET drugs are available?
AVET has forty approved drugs.
Summary for Avet
| US Patents: | 0 |
| Tradenames: | 37 |
| Ingredients: | 36 |
| NDAs: | 40 |
Drugs and US Patents for Avet
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avet Lifesciences | RIZATRIPTAN BENZOATE | rizatriptan benzoate | TABLET;ORAL | 204090-002 | Nov 26, 2013 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Avet Lifesciences | PALONOSETRON HYDROCHLORIDE | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 202951-001 | Jun 29, 2021 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
| Avet Lifesciences | PENTAMIDINE ISETHIONATE | pentamidine isethionate | INJECTABLE;INJECTION | 213806-001 | Jan 7, 2021 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Avet Lifesciences | TRANEXAMIC ACID | tranexamic acid | INJECTABLE;INJECTION | 203521-001 | Aug 12, 2014 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Avet Lifesciences | ACARBOSE | acarbose | TABLET;ORAL | 202271-001 | Feb 7, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Avet Lifesciences | FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE | fosinopril sodium; hydrochlorothiazide | TABLET;ORAL | 079025-002 | Sep 17, 2010 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
